APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 262 filers reported holding APELLIS PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.39 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $12,420,326 | -58.2% | 326,507 | 0.0% | 0.09% | -59.1% |
| Q2 2023 | $29,744,788 | +10.5% | 326,507 | -26.4% | 0.22% | +15.0% |
| Q1 2023 | $26,925,971 | +87.0% | 443,507 | +59.2% | 0.19% | +92.8% |
| Q4 2022 | $14,400,922 | -38.6% | 278,507 | -18.9% | 0.10% | -41.2% |
| Q3 2022 | $23,463,000 | -15.7% | 343,507 | -44.2% | 0.16% | -27.9% |
| Q2 2022 | $27,830,000 | +17.5% | 615,457 | +32.0% | 0.23% | +42.2% |
| Q1 2022 | $23,681,000 | -27.9% | 466,095 | -32.9% | 0.16% | -23.3% |
| Q4 2021 | $32,832,000 | +290.6% | 694,425 | +172.3% | 0.21% | +268.4% |
| Q3 2021 | $8,405,000 | -58.1% | 255,030 | -19.6% | 0.06% | -58.4% |
| Q2 2021 | $20,054,000 | -34.3% | 317,315 | -42.9% | 0.14% | -46.1% |
| Q1 2021 | $30,515,000 | -3.9% | 555,374 | 0.0% | 0.25% | +1.2% |
| Q4 2020 | $31,769,000 | -8.3% | 555,374 | -51.7% | 0.25% | -23.0% |
| Q3 2020 | $34,660,000 | -12.3% | 1,148,865 | -5.1% | 0.33% | -21.8% |
| Q2 2020 | $39,533,000 | +236.7% | 1,210,398 | +208.6% | 0.42% | +220.8% |
| Q1 2020 | $11,740,000 | -2.2% | 392,200 | 0.0% | 0.13% | +0.8% |
| Q4 2019 | $12,009,000 | +14.7% | 392,200 | -9.8% | 0.13% | -7.2% |
| Q3 2019 | $10,472,000 | -21.3% | 434,700 | -17.6% | 0.14% | -16.3% |
| Q2 2019 | $13,313,000 | +29.4% | 527,700 | 0.0% | 0.17% | +25.8% |
| Q1 2019 | $10,291,000 | +47.9% | 527,700 | 0.0% | 0.13% | +23.4% |
| Q4 2018 | $6,960,000 | -24.1% | 527,700 | +2.3% | 0.11% | -12.3% |
| Q3 2018 | $9,169,000 | +73.7% | 515,700 | +114.9% | 0.12% | +45.2% |
| Q2 2018 | $5,280,000 | +92.6% | 240,000 | +93.5% | 0.08% | +78.7% |
| Q1 2018 | $2,742,000 | +8.0% | 124,000 | +6.0% | 0.05% | +6.8% |
| Q4 2017 | $2,539,000 | – | 117,000 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Octagon Capital Advisors LP | 3,130,000 | $119,065,200 | 18.29% |
| EcoR1 Capital, LLC | 10,899,859 | $414,630,636 | 13.99% |
| Ally Bridge Group (NY) LLC | 181,805 | $6,915,862 | 8.12% |
| Avoro Capital Advisors LLC | 11,111,111 | $422,666,662 | 6.59% |
| ACUTA CAPITAL PARTNERS, LLC | 244,484 | $9,300,171 | 6.23% |
| Iron Triangle Partners LP | 880,000 | $33,475,200 | 4.89% |
| Cormorant Asset Management, LP | 2,000,000 | $76,080,000 | 4.44% |
| Octagon Capital Advisors LP | 675,000 | $25,677,000 | 3.94% |
| Logos Global Management LP | 750,000 | $28,530,000 | 3.81% |
| Boxer Capital, LLC | 1,726,000 | $65,657,040 | 3.50% |